Portfolio company
Entegrion
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This life sciences company develops point-of-care blood coagulation monitoring systems and hemostatic products for clinicians in civilian and military medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
410 Medical
This company develops handheld rapid infusion devices to deliver fluids and blood to critically ill patients for hospitals and emergency medical services.
Accumetrics
The company develops and manufactures platelet function testing systems for medical professionals to assess the effectiveness of antiplatelet medications in patients.
InCurA
This company develops and manufactures hemostatic agents and advanced wound care devices for dental, surgical, accident, and military applications.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
Enzyre
This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.
Coagulant Therapeutics
This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.
Contego Medical
This company develops integrated embolic protection devices and catheters for healthcare professionals performing carotid and peripheral vascular revascularisation procedures.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
